Level Four Advisory Services, LLC Immunic, Inc. Transaction History
Level Four Advisory Services, LLC
- $2.66 Billion
- Q3 2025
A detailed history of Level Four Advisory Services, LLC transactions in Immunic, Inc. stock. As of the latest transaction made, Level Four Advisory Services, LLC holds 10,780 shares of IMUX stock, worth $8,085. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,780
Previous 10,780
-0.0%
Holding current value
$8,085
Previous $7,000
28.57%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IMUX
# of Institutions
69Shares Held
42.5MCall Options Held
128KPut Options Held
90.7K-
Abrdn PLC8.24MShares$6.18 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA7.65MShares$5.74 Million0.35% of portfolio
-
Avidity Partners Management LP Dallas, TX4.7MShares$3.52 Million2.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$3.26 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.1MShares$2.33 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $22.9M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...